Rx ruling may affect Weitzel
Prescription ruling may affect Weitzel
Family won case after claiming doctor underprescribed for pain
Thr, June 28, 2001 00:00:00
By NESREEN KHASHAN
Standard-Examiner Davis Bureau
FARMINGTON -- A landmark ruling issued earlier this month awarding
damages to a family who accused a doctor of underprescribing pain
medication has cast new scrutiny on the trial of a Farmington doctor
accused of causing the deaths of five elderly patients by
overprescribing drugs.
In the Northern California case, a jury awarded $1.5 million to the
family of William Bergman, who died of cancer in 1998 at the age of
85. According to the family, Dr. Wing Chin underprescribed Bergman
pain medication although the terminally ill man was in excruciating
pain.
The ruling was the first of its kind because it likened the
underprescription of pain to elder abuse, said Kathryn Tucker, legal
director of the Oregon nonprofit Compassion in Dying Federation and
co-counsel in the civil suit.
In a May 8 brief to Davis County Attorney Melvin Wilson and Utah
Attorney General Mark Shurtleff, Tucker urged the prosecutors not to
proceed with the retrial of Farmington physician Dr. Robert Weitzel,
accused of murdering five of his patients by prescribing lethal
doses of morphine. Although convicted on lesser homicide charges,
Weitzel earlier this year won the right to a new trial.
Tucker said her fear is that the Weitzel case, contrasted with the
case of Chin, could send confusing signals to a medical community
already grappling with pain-management issues.
"What we were trying to do was bring to the attention of prosecuting
authorities that there is already a terrible problem of
undertreatment of pain, particularly in the elderly population,"
Tucker said.
"We are concerned that when physicians treating the pain of elderly
terminally ill patients are punished, it increases the chill in this
environment that causes them to be unwilling to prescribe
adequately."
Instead, Tucker urges authorities to resolve criticisms regarding a
physician's care of patients in a professional disciplinary context.
Wilson, defending his office's decision to reprosecute, said the
doses administered by Weitzel indicated an intent to euthanize the
patients. Weitzel is scheduled to be back in court for a double
jeopardy hearing on Friday.
"I'm all for appropriate treatment," Wilson said. "But the medical
treatment rendered by Dr. Weitzel had nothing to do with pain."
A Brown University study released in May that ranked Utah lowest in
the country in providing pain relief to elderly patients in nursing
homes has sharpened the end-of-life care debate even more locally.
A letter published in the Journal of the American Medical
Association summarizing the study stated that on average 41.5
percent of the nation's nursing home residents suffered from
persistent pain, with Utah leading the country at 49.5 percent.
Utah medical personnel and administrators working in the nursing
home or hospice care fields will meet in Salt Lake City this week to
discuss the Brown study. Dr. Greg Miller, medical director of
Intermountain Health Care Hospice for Salt Lake City and Ogden, said
Weitzel's retrial could thwart this and other ongoing statewide
efforts to educate doctors and patients on pain-management issues.
"We are all very concerned about any event that would increase the
barriers for people to receive adequate management to their pain,"
said Miller.
Although there is new evidence that the data used by Brown
researchers was either flawed or misinterpreted, the Utah medical
community can still benefit from the report, said Allan Elkins,
director of the Utah Department of Health Bureau of
Medicare/Medicaid Program Certification.
Brown researchers apparently overestimated by more than 5,000 the
number of patients in Utah's nursing homes in the spring of 1999,
said Elkins, whose agency compiles the data for the federal
government. Elkins said his agency is looking into the discrepancies
and is planning to replicate the Brown study to see if the same
conclusion is reached. But until then, he hopes to make strides in
teaching patients and doctors alike about pain-management
assessment. "Certainly we agree that pain management is very
important and something all facilities should do a good job on,"
said Elkins.
Not everyone, however, is convinced that Weitzel's retrial will
cause physicians to reconsider treating their patients properly for
pain. Mark Fotheringham, spokesman for the Utah Medical Association,
called the Weitzel case, both last July's trial and the upcoming
prosecution, "more of an aberration than a trend."
"We have gone to great lengths to educate our members that they
should not fear prescribing narcotics for pain control,"
Fotheringham said. "There is no evidence of a statewide witch hunt.
Nobody has anything to fear." Right...
Copyright ©2001, Ogden Publishing Corporation
<<Back
to Home Page